Paxerol (a Novel Formulation of Acetaminophen and Ibuprofen) for Treatment of Nocturia - A Phase II Placebo-Controlled Trial
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Ibuprofen/paracetamol (Primary)
- Indications Nocturia
- Focus Therapeutic Use
- Sponsors Wellesley Pharmaceuticals
- 01 Nov 2016 Planned End Date changed from 1 Jul 2016 to 1 Mar 2017.
- 01 Nov 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Feb 2017.
- 04 Apr 2016 Planned number of patients changed from 40 to 100 as reported by ClinicalTrials.gov record.